glp 1 injection or oral GLP-1 Therapy: Pills vs Injections? US FDA accepts Novo Nordisk's
Description
On Wednesday 4/1/26, the Food and Drug Administration (FDA) approved Eli Lillys new oral weight-loss pill, orforglipron , a GLP-1 drug that works like the widely used injectable medications
Insurance coverage is not a clinical difference
Studies on Dipeptidyl(Amino)Peptidase IV (Glycyl-Proline Naphthylamidase)
The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with chronic kidney disease and type 2 diabetes
Pastorelli L, Garg RR, Hoang SB, et al
